New COPD drug candidate begins first human safety tests
NCT ID NCT07554365
First seen May 15, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This early-stage study tests an inhaled powder called AN01 in 24 healthy adults to see if it is safe and how the body processes it. AN01 is being developed as a possible treatment for COPD, a lung disease that makes breathing hard. The study does not offer any direct treatment benefit to participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site 103
RECRUITINGAdelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.